Analysts expect Valneva to post earnings of ($0.22) per share and revenue of $55.64 million for the quarter. Valneva Trading Up 0.1 % NASDAQ VALN opened at $6.80 on Monday.

If granted, IXCHIQ ® will become the first vaccine against the chikungunya virus (CHIKV) available in the EU for adolescents 12 years of age and older Saint Herblain (France), February 28, 2025 - ...

Saint-Herblain (France), March 3, 2025 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) a specialty vaccine company, today announced that its senior management will participate at upcoming investor ...

VALNEVA Declaration of shares and voting rights February 28, 2025_____ Company name: VALNEVARegistered office ...

Valneva has bolstered its vaccines pipeline with a shot designed to protect against shigellosis – a major global health threat – licensed from LimmaTech Biologics. The French pharma company ...

New data for Valneva and Pfizer's experimental vaccine for Lyme disease – the furthest ahead in clinical testing – have bolstered the case for the shot as the results of a phase 3 programme ...

Adi Hutter’s side stay fourth and could lose contact with second-placed Olympique de Marseille and Nice, in third, who play Lens and Olympiaue Lyonnais this weekend. Monaco are also under threat ...

Dr. Saulos Klaus Chilima signed an agreement that ultimately led to his death. If the Malawi Congress Party (MCP) now claims that President Lazarus Chakwera will run again in 2025, it means they have ...

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.